Insights

Innovative Imaging Technology MILabs specializes in high-performance multimodal preclinical imaging systems that integrate SPECT, PET, CT, and Optical imaging, providing comprehensive data for molecular and in vivo research. This advanced technology appeals to research institutions and pharmaceutical companies investing in cutting-edge diagnostic tools.

Growing Global Presence With over 300 imaging modules installed worldwide and collaborations with leading academic, clinical, and industry partners, MILabs demonstrates a solid international footprint, creating opportunities for sales expansion in universities, hospitals, and CROs across diverse markets.

Recent Strategic Acquisitions The acquisition of MILabs by Rigaku Corporation and Bayer AG reflects its strategic value in molecular imaging and preclinical research, indicating increased credibility and potential for future collaborations, investment, and sales opportunities with organizations focused on advanced biomedical research.

Product Innovation & Recognition Awards such as the Commercial Innovation of the Year and the launch of new imaging modules like Duet Optical Imaging and the E-Class line highlight MILabs’ commitment to innovation, making it a compelling partner for clients seeking the latest in preclinical imaging solutions.

Market Segment Focus Target markets include biomedical research institutions, hospitals, and pharmaceutical companies conducting disease research and developing new diagnostics and therapies, especially in areas like oncology, neurodegeneration, and diabetes, offering multiple avenues for tailored sales pitches.

MILabs B.V. Tech Stack

MILabs B.V. uses 8 technology products and services including Twemoji, Font Awesome, imagesLoaded, and more. Explore MILabs B.V.'s tech stack below.

  • Twemoji
    Font Scripts
  • Font Awesome
    Font Scripts
  • imagesLoaded
    Javascript Libraries
  • Cloudways
    Platform As A Service
  • Google Analytics
    Web Analytics
  • Astra
    Web Platform Extensions
  • Gravity Forms
    Web Platform Extensions
  • Facebook
    Widgets

Media & News

MILabs B.V.'s Email Address Formats

MILabs B.V. uses at least 1 format(s):
MILabs B.V. Email FormatsExamplePercentage
F.Last@milabs.comJ.Doe@milabs.com
42%
First@milabs.comJohn@milabs.com
22%
FLast@milabs.comJDoe@milabs.com
21%
First.Last@milabs.comJohn.Doe@milabs.com
15%

Frequently Asked Questions

Where is MILabs B.V.'s headquarters located?

Minus sign iconPlus sign icon
MILabs B.V.'s main headquarters is located at 7a Duwboot Houten, Utrecht 3991 cd Netherlands. The company has employees across 5 continents, including EuropeNorth AmericaAsia.

What is MILabs B.V.'s official website and social media links?

Minus sign iconPlus sign icon
MILabs B.V.'s official website is milabs.com and has social profiles on LinkedInCrunchbase.

What is MILabs B.V.'s SIC code NAICS code?

Minus sign iconPlus sign icon
MILabs B.V.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does MILabs B.V. have currently?

Minus sign iconPlus sign icon
As of March 2026, MILabs B.V. has approximately 59 employees across 5 continents, including EuropeNorth AmericaAsia. Key team members include Chief Executive Officer: T. V. E.Chief Operating Officer: R. J. S.Principal Imaging Scientist / Business Director: C. W.. Explore MILabs B.V.'s employee directory with LeadIQ.

What industry does MILabs B.V. belong to?

Minus sign iconPlus sign icon
MILabs B.V. operates in the Biotechnology Research industry.

What technology does MILabs B.V. use?

Minus sign iconPlus sign icon
MILabs B.V.'s tech stack includes TwemojiFont AwesomeimagesLoadedCloudwaysGoogle AnalyticsAstraGravity FormsFacebook.

What is MILabs B.V.'s email format?

Minus sign iconPlus sign icon
MILabs B.V.'s email format typically follows the pattern of F.Last@milabs.com. Find more MILabs B.V. email formats with LeadIQ.

MILabs B.V.

Biotechnology ResearchUtrecht, Netherlands51-200 Employees

MILabs provides high performance standalone and integrated preclinical SPECT, PET, CT and Optical Imaging systems for molecular imaging and in vivo imaging research. The 4x4D multimodal imaging technology, each with four-dimensional imaging capabilities enables researchers to improve diagnostics and therapy development through complementary, data-rich, co-registered images. Each modality by itself gives data beyond the capabilities of any other stand-alone system. 

Our mission is to make molecular imaging clear. Through continuous innovation and supportive service, the team at MILabs is dedicated to ‘providing small details for big discoveries’ for a wide range of imaging research programs.  With over 300 imaging modules installed worldwide, our fast-growing company collaborates with leading universities, hospitals, contract research organizations and pharmaceutical companies.  The systems contribute significantly to the development of new diagnostic solutions and therapies for diseases such as diabetes, cancer, cardiac and neurodegenerative diseases.

Explore how the cutting-edge preclinical imaging and clinical technologies can accelerate research discoveries at www.milabs.com

Section iconCompany Overview

Headquarters
7a Duwboot Houten, Utrecht 3991 cd Netherlands
Website
milabs.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
51-200

Section iconFunding & Financials

  • $1M$10M

    MILabs B.V.'s revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1M$10M

    MILabs B.V.'s revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.